Mana.bio
San Francisco, United States · Founded 2021 · $19.5M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- mana.bio
- Total Funding
- $19.5M
- Last Round
- $19.5M SeedOct 2023
- Rounds
- 1
About
AI-powered design of lipid nanoparticles (LNPs) for genetic medicines with better safety and tropism
Summary
Mana.bio is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. It has raised $19.5M in total across 1 round, most recently a $19.5M Seed round in Oct 2023.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2023
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company